GVD, value toolkit and economic model development for a new therapy for acromegaly​

• The client had developed a new therapy for the treatment for acromegaly ​
• The cross-functional team required strategic support with defining the value narrative, and using this to inform the Global Value Dossier (GVD), health economic model and accompanying presentation for communicating the holistic value of the treatment with external stakeholders​
• The team also required support with adapting the GVD and economic model for US AMCP submission  ​

‍

• Develop the GVD for the new therapy based on existing internal information and targeted literature searching to address any gaps​
• Development of a presentation summarising the payer value narrative (based on key content from the GVD) for use in field-based stakeholder interactions ​
• Development of the AMCP dossier and supporting health economic model for use in US payer/formulary stakeholder interactions ​

‍

• Internal alignment with the cross-functional client team to review/define the value narrative​
• Drafting of the GVD (including an iterative review process with the cross-functional client team)​
• Development of the summary slide deck defining the payer value narrative ​
• Development of the AMCP dossier (with adaptation of the GVD in line with US payer requirements)​
• Development of a user-friendly US budget impact model for US payer engagement ​

• Development of a GVD to support the  agreed clinical/humanistic/economic value narrative for the new asset​
• Development of a user-friendly presentation summarising the payer value narrative for use in field-based stakeholder interactions​
• Delivery of a suite of US value communication resources including the finalised AMCP dossier and user-friendly dynamic budget impact model for US payer interactions ​

‍